K
Kranus Health
AI-powered digital therapies for urological conditions.
About Kranus Health
Kranus Health is building the world's first AI-enabled gender medicine platform — a new category of care for urological, gynecological, and hormonal conditions that affect more than a billion people globally yet remain systematically under-treated.
Read full description
Headquartered in Munich, the company develops clinically validated digital therapy programsranging from urinary incontinence to benign prostatic hyperplasia and overactive bladder, with a pipeline extending into prostate cancer, menopause, breast cancer, and endometriosis. All launched products are permanently reimbursed under Germany's DiGA framework, one of the world's most rigorous digital health standards, and are backed by randomized controlled trials published in NEJM Evidence, The Lancet Digital Health, and European Urology Focus.
A regulated, AI-native software factory enables the company to launch new therapeutic indications at unprecedented speed, reshaping the economics of digital medicine.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Munich, Germany
- Employees
- 72
- Open positions
- 8
- Dealroom signal
- 68.1/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices
- Sector
- Biotech & Life Sciences, Fertility, Core AI, Sustainable Development Goals, Sextech, Digital Therapeutics, Mentech, Tech for Patients
- Technology
- Artificial Intelligence, Big Data, Mobile app
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Kranus Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2024 | $5M | $75M | Future Positive Capital · CapHorn | ↗ |
| SERIES A✓Equity / VC | Oct 2023 | $15M | $60M | A-Round Capital · Venture Basecamp · Karista · HTGF | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Kranus Health is 20K monthly website visits, down 23.1% over the last three months. Kranus Health's team grew 9.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Konstantin Mehl
Series A10 investors entered at this stage
Karista
SwissHealth Ventures- ACA-Round Capital
- VBVenture Basecamp
HTGF
Peak Pride
WENVEST Capital
Ralph Müller
Future Positive Capital
CapHorn
Other known investors4 additional known investors
Christophe Aumaître
Florian Brand
Prof Ehsan Khaljani
SB21 - Saarbruecker21
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kranus Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kranus Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.